Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis

Figure 1 Immunohistochemical staining for heat shock protein 110 in gastric cancer patients. A: Representative images of gastric cancer. Representative images indicating the intensity of nuclear HSP110 staining (upper panel) and the percentage of nuclear-stained gastric cancer cells (lower panel) are shown. B: The three-year progression-free survival curve of 14 gastric cancer patients according to their nuclear HSP110 expression. HSP110: Heat shock protein 110.